Study finds allergy shots work regardless of dose or allergy severity
Allergic to peanuts? Bees? Pollen? Cockroaches? There’s a shot for that.
Allergic to peanuts? Bees? Pollen? Cockroaches? There’s a shot for that.
Brazilian researchers have taken an important step toward precision medicine by identifying four genes that can predict which melanoma patients will not respond to immunotherapy. Although this treatment has revolutionized the fight against melanoma, th…
Researchers led by the University of Geneva and École Polytechnique Fédérale de Lausanne report that neural anticipation of virtual infection triggers an immune response through activation of innate lymphoid cells.
Modupe O. Coker from the School of Dental Medicine and a collaborative team of researchers identified changes over time in the oral microbiome of children living with HIV, offering insights into how early immune challenges shape not only oral health bu…
Cancer cells mount an instant, energy‑rich response to being physically squeezed, according to a study published in the journal Nature Communications. The surge of energy is the first reported instance of a defensive mechanism that helps cells repair D…
A new discovery made by researchers from The Australian National University (ANU) could lead to smarter, more effective treatments for Hodgkin lymphoma, a common blood cancer.
Weill Cornell Medicine researchers have discovered that PD-1—a molecule best known for putting the brakes on immune cells—also plays a critical role in helping T cells become long-term immune defenders in the skin. Early during infection, PD-1 acts lik…
Of the 3.6 million babies born in the United States each year, about 80% begin breastfeeding in their first month of life. Breastfeeding has known benefits for both mother and child, reducing maternal risk of breast and ovarian cancers, type 2 diabetes…
Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of treatment—immunotherapy—may help change the environment where cancer cells live, possibly helping the immune system respond more effe…
New designer proteins created using an AI tool can selectively target peptide segments that bind to markers on diseased cancer cells, acting like molecular flags that signal immune cells to attack and destroy the threats.